Listeria monocytogenes genome, polypeptides and uses
CA 2404988 A1 · Owner: Buchrieser, Carmen · Inventors: Karst, Uwe; Rose, Matthias; Entian, Karl-Dieter
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns the genome sequence and nucleotide sequences of Listeria monocytogenes EGD-e. The invention also concerns polypeptides of said organism in particular surface or cell envelope polypeptides or polypeptides involved in the different metabolism cycles in particular vitamin B12 biosynthesis. The invention further concerns uses of said sequences and various tools enabling identification of L. monocytogenes or associated species. Finally the invention concerns modified <I>L</I>. monocytogenes strains and pharmaceutical or vaccine compositions using the inventive sequences.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 11, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 11, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 11, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.